IRIS
RUSSO, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.117
EU - Europa 856
AS - Asia 606
SA - Sud America 273
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.866
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.093
PL - Polonia 277
BR - Brasile 245
SG - Singapore 244
IE - Irlanda 173
CN - Cina 163
SE - Svezia 132
IT - Italia 113
HK - Hong Kong 81
FR - Francia 45
VN - Vietnam 44
RU - Federazione Russa 23
DE - Germania 20
FI - Finlandia 18
BE - Belgio 16
CA - Canada 14
ID - Indonesia 14
IN - India 14
UA - Ucraina 12
AR - Argentina 10
GB - Regno Unito 8
UZ - Uzbekistan 7
BD - Bangladesh 6
JP - Giappone 6
MX - Messico 6
EC - Ecuador 5
ZA - Sudafrica 5
AT - Austria 4
ES - Italia 4
IQ - Iraq 4
KR - Corea 4
TR - Turchia 4
CO - Colombia 3
PK - Pakistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
IL - Israele 2
KE - Kenya 2
LT - Lituania 2
NL - Olanda 2
PE - Perù 2
PY - Paraguay 2
UY - Uruguay 2
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
CL - Cile 1
EG - Egitto 1
EU - Europa 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
MD - Moldavia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 2.866
Salva come PNG Salva come JPEG
Città #
Warsaw 274
Dublin 173
Chandler 168
Ashburn 156
Singapore 107
Dallas 86
Hong Kong 81
Beijing 69
Nyköping 67
Messina 45
Ann Arbor 43
New York 43
Dearborn 34
Princeton 34
Jacksonville 33
The Dalles 27
Los Angeles 26
Medford 26
Des Moines 23
Dong Ket 18
Brussels 16
Cambridge 16
Fort Washington 14
Wilmington 14
Buffalo 12
São Paulo 12
Ho Chi Minh City 11
Jinan 11
Jakarta 10
Munich 10
Houston 9
Belo Horizonte 8
Redondo Beach 8
Shenyang 8
Woodbridge 8
Boardman 7
Falls Church 7
San Mateo 7
Seattle 7
Stockholm 7
Tashkent 7
Tianjin 7
Toronto 7
Guangzhou 6
Moscow 6
Pune 6
Brooklyn 5
Hebei 5
Nanjing 5
Rio de Janeiro 5
San Francisco 5
Tokyo 5
Anagni 4
Brasília 4
Cagliari 4
Chennai 4
Curitiba 4
Dongdaemun-gu 4
Fairfield 4
Hanoi 4
Nanchang 4
Redwood City 4
Zhengzhou 4
Aracaju 3
Atlanta 3
Barretos 3
Brockport 3
Campinas 3
Dhaka 3
Hangzhou 3
Indaiatuba 3
Joinville 3
Juiz de Fora 3
London 3
Mexico City 3
Mogi Mirim 3
Nuremberg 3
Radomsko 3
Santa Clara 3
Turku 3
Abidjan 2
Americana 2
Ankara 2
Anápolis 2
Araxá 2
Araçatuba 2
Auburn Hills 2
Barueri 2
Betim 2
Bogotá 2
Buenos Aires 2
Burgas 2
Camaçari 2
Caratinga 2
Concórdia 2
Cotia 2
Council Bluffs 2
Cuiabá 2
Denver 2
Diadema 2
Totale 1.939
Salva come PNG Salva come JPEG
Nome #
Exosomal PD-L1 expression and dynamic changes of immune response associated cytokines as predictive biomarkers for immune checkpoint blockage with PD-1/PD-L1 inhibitors in advanced/metastatic non-small cell lung cancer 204
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives 173
Baseline neutrophilia, derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel 154
Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases 124
Nab-paclitaxel and trastuzumab combination: A promising approach for neoadjuvant treatment in HER2-positive breast cancer 124
Can we better manage advanced NSCLC in the elderly with the new therapeutic agents? Preliminary analysis of a real life multicenter study. 121
Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: New directions for systemic therapy - a case report and literature review 120
Heterogeneous responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with uncommon EGFR mutations: New insights and future perspectives in this complex clinical scenario 120
Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer 114
Influence of EGFR mutational status on metastatic behavior in non squamous non small cell lung cancer 111
Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going 109
Long time response with chemotherapy in ROS1 NSCLC patient with unusual metastatic site 109
Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance 108
NSCLC and HER2: between lights and shadows 107
The changing scenario of 1st line therapy in non-oncogene addicted NSCLCs in the era of immunotherapy 101
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status 100
Rapid Acquisition of T790M Mutation after Treatment with Afatinib in an NSCLC Patient Harboring EGFR Exon 20 S768I Mutation 97
Liquid biopsy tracking of lung tumor evolutions over time 95
Impact of erlotinib on overall survival in non small cell lung cancer patients: is the post progression survival a new paradigm? 92
Impact of circulating microRNAs mir-22, mir-24 and mir-34a on response to pemetrexed in patients with non small cell lung cancer 88
Immunotherapy use in patients with HIV and non-small-cell lung cancer: Current data 87
How I treat ALK-positive non-small cell lung cancer 83
1995PApplication of ESCAT and OncoKB scales in liquid biopsy (LB) in advanced NSCLC patients (pts): Is it feasible and reliable? 83
Is There Room for Personalized Medicine in Small-Cell Lung Cancer (SCLC)? Remarkable Activity of Pazopanib in Refractory FGFR1-Amplified ED-SCLC 76
Concomitant medications during immune checkpoint blockage in cancer patients: Novel insights in this emerging clinical scenario 74
Acquired resistance in oncogene-addicted non-small-cell lung cancer 66
Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study 59
Treatment option for small cell lung cancer: does lanreotide represent a new choice? 57
Totale 2.956
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.498
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.498
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021210 0 0 0 0 0 25 46 25 35 49 10 20
2021/2022226 1 24 7 7 9 9 14 9 1 39 35 71
2022/2023527 37 56 19 44 35 47 7 45 217 3 12 5
2023/2024146 8 25 8 9 12 58 2 10 1 1 0 12
2024/2025625 3 5 7 36 59 18 51 155 119 28 44 100
2025/2026613 101 108 126 110 157 11 0 0 0 0 0 0
Totale 2.956